An HIV vaccine may have the purpose of protecting individuals who do not have HIV from being infected with the virus (a preventative vaccine), or treating an HIV-infected person (a therapeutic vaccine). There are two approaches to an HIV vaccine: an active vaccination approach in which a vaccine aims to induce an immune response against HIV; and a passive vaccination approach in which preformed antibodies against HIV are administered.
Based on the Hiv Vaccine market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Hiv Vaccine market covered in Chapter 5:
Sanofi
Paxvax Corporation
Glaxosmithkline
Inovio Pharmaceuticals
Argos Therapeutics
Janssen Global Services
Bionor Pharma
Genecure
Geovax,
In Chapter 6, on the basis of types, the Hiv Vaccine market from 2015 to 2025 is primarily split into:
Therapeutic vaccine
Preventive vaccine
In Chapter 7, on the basis of applications, the Hiv Vaccine market from 2015 to 2025 covers:
Infants
Early aged
Post aged
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Hiv Vaccine Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Sanofi
5.1.1 Sanofi Company Profile
5.1.2 Sanofi Business Overview
5.1.3 Sanofi Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Sanofi Hiv Vaccine Products Introduction
5.2 Paxvax Corporation
5.2.1 Paxvax Corporation Company Profile
5.2.2 Paxvax Corporation Business Overview
5.2.3 Paxvax Corporation Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Paxvax Corporation Hiv Vaccine Products Introduction
5.3 Glaxosmithkline
5.3.1 Glaxosmithkline Company Profile
5.3.2 Glaxosmithkline Business Overview
5.3.3 Glaxosmithkline Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Glaxosmithkline Hiv Vaccine Products Introduction
5.4 Inovio Pharmaceuticals
5.4.1 Inovio Pharmaceuticals Company Profile
5.4.2 Inovio Pharmaceuticals Business Overview
5.4.3 Inovio Pharmaceuticals Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Inovio Pharmaceuticals Hiv Vaccine Products Introduction
5.5 Argos Therapeutics
5.5.1 Argos Therapeutics Company Profile
5.5.2 Argos Therapeutics Business Overview
5.5.3 Argos Therapeutics Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Argos Therapeutics Hiv Vaccine Products Introduction
5.6 Janssen Global Services
5.6.1 Janssen Global Services Company Profile
5.6.2 Janssen Global Services Business Overview
5.6.3 Janssen Global Services Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Janssen Global Services Hiv Vaccine Products Introduction
5.7 Bionor Pharma
5.7.1 Bionor Pharma Company Profile
5.7.2 Bionor Pharma Business Overview
5.7.3 Bionor Pharma Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Bionor Pharma Hiv Vaccine Products Introduction
5.8 Genecure
5.8.1 Genecure Company Profile
5.8.2 Genecure Business Overview
5.8.3 Genecure Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Genecure Hiv Vaccine Products Introduction
5.9 Geovax,
5.9.1 Geovax, Company Profile
5.9.2 Geovax, Business Overview
5.9.3 Geovax, Hiv Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Geovax, Hiv Vaccine Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Hiv Vaccine Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Hiv Vaccine Sales and Market Share by Types (2015-2020)
6.1.2 Global Hiv Vaccine Revenue and Market Share by Types (2015-2020)
6.1.3 Global Hiv Vaccine Price by Types (2015-2020)
6.2 Global Hiv Vaccine Market Forecast by Types (2020-2025)
6.2.1 Global Hiv Vaccine Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Hiv Vaccine Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Hiv Vaccine Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Hiv Vaccine Sales, Price and Growth Rate of Therapeutic vaccine
6.3.2 Global Hiv Vaccine Sales, Price and Growth Rate of Preventive vaccine
6.4 Global Hiv Vaccine Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Therapeutic vaccine Market Revenue and Sales Forecast (2020-2025)
6.4.2 Preventive vaccine Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Hiv Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Hiv Vaccine Sales and Market Share by Applications (2015-2020)
7.1.2 Global Hiv Vaccine Revenue and Market Share by Applications (2015-2020)
7.2 Global Hiv Vaccine Market Forecast by Applications (2020-2025)
7.2.1 Global Hiv Vaccine Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Hiv Vaccine Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Hiv Vaccine Revenue, Sales and Growth Rate of Infants (2015-2020)
7.3.2 Global Hiv Vaccine Revenue, Sales and Growth Rate of Early aged (2015-2020)
7.3.3 Global Hiv Vaccine Revenue, Sales and Growth Rate of Post aged (2015-2020)
7.4 Global Hiv Vaccine Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Infants Market Revenue and Sales Forecast (2020-2025)
7.4.2 Early aged Market Revenue and Sales Forecast (2020-2025)
7.4.3 Post aged Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Hiv Vaccine Sales by Regions (2015-2020)
8.2 Global Hiv Vaccine Market Revenue by Regions (2015-2020)
8.3 Global Hiv Vaccine Market Forecast by Regions (2020-2025)
9 North America Hiv Vaccine Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Hiv Vaccine Market Sales and Growth Rate (2015-2020)
9.3 North America Hiv Vaccine Market Revenue and Growth Rate (2015-2020)
9.4 North America Hiv Vaccine Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Hiv Vaccine Market Analysis by Country
9.6.1 U.S. Hiv Vaccine Sales and Growth Rate
9.6.2 Canada Hiv Vaccine Sales and Growth Rate
9.6.3 Mexico Hiv Vaccine Sales and Growth Rate
10 Europe Hiv Vaccine Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Hiv Vaccine Market Sales and Growth Rate (2015-2020)
10.3 Europe Hiv Vaccine Market Revenue and Growth Rate (2015-2020)
10.4 Europe Hiv Vaccine Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Hiv Vaccine Market Analysis by Country
10.6.1 Germany Hiv Vaccine Sales and Growth Rate
10.6.2 United Kingdom Hiv Vaccine Sales and Growth Rate
10.6.3 France Hiv Vaccine Sales and Growth Rate
10.6.4 Italy Hiv Vaccine Sales and Growth Rate
10.6.5 Spain Hiv Vaccine Sales and Growth Rate
10.6.6 Russia Hiv Vaccine Sales and Growth Rate
11 Asia-Pacific Hiv Vaccine Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Hiv Vaccine Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Hiv Vaccine Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Hiv Vaccine Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Hiv Vaccine Market Analysis by Country
11.6.1 China Hiv Vaccine Sales and Growth Rate
11.6.2 Japan Hiv Vaccine Sales and Growth Rate
11.6.3 South Korea Hiv Vaccine Sales and Growth Rate
11.6.4 Australia Hiv Vaccine Sales and Growth Rate
11.6.5 India Hiv Vaccine Sales and Growth Rate
12 South America Hiv Vaccine Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Hiv Vaccine Market Sales and Growth Rate (2015-2020)
12.3 South America Hiv Vaccine Market Revenue and Growth Rate (2015-2020)
12.4 South America Hiv Vaccine Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Hiv Vaccine Market Analysis by Country
12.6.1 Brazil Hiv Vaccine Sales and Growth Rate
12.6.2 Argentina Hiv Vaccine Sales and Growth Rate
12.6.3 Columbia Hiv Vaccine Sales and Growth Rate
13 Middle East and Africa Hiv Vaccine Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Hiv Vaccine Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Hiv Vaccine Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Hiv Vaccine Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Hiv Vaccine Market Analysis by Country
13.6.1 UAE Hiv Vaccine Sales and Growth Rate
13.6.2 Egypt Hiv Vaccine Sales and Growth Rate
13.6.3 South Africa Hiv Vaccine Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Hiv Vaccine Market Size and Growth Rate 2015-2025
Table Hiv Vaccine Key Market Segments
Figure Global Hiv Vaccine Market Revenue ($) Segment by Type from 2015-2020
Figure Global Hiv Vaccine Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Hiv Vaccine
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Sanofi Company Profile
Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Summary: Get latest Market Research Reports on Hiv Vaccine. Industry analysis & Market Report on Hiv Vaccine is a syndicated market report, published as Global Hiv Vaccine Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Hiv Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.